520 related articles for article (PubMed ID: 29434587)
1. Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment.
Sormendi S; Wielockx B
Front Immunol; 2018; 9():40. PubMed ID: 29434587
[TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma.
Singh M; Devi U; Roy S; Gupta PS; Saraf SA; Kaithwas G
Breast Cancer; 2016 Nov; 23(6):820-829. PubMed ID: 26951539
[TBL] [Abstract][Full Text] [Related]
3. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism.
Nguyen TL; Durán RV
Int J Biochem Cell Biol; 2016 Nov; 80():71-80. PubMed ID: 27702652
[TBL] [Abstract][Full Text] [Related]
4. Oxygen sensors as therapeutic targets in kidney disease.
Haase VH
Nephrol Ther; 2017 Apr; 13 Suppl 1():S29-S34. PubMed ID: 28577740
[TBL] [Abstract][Full Text] [Related]
5. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
[TBL] [Abstract][Full Text] [Related]
6. pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner.
Guo J; Chakraborty AA; Liu P; Gan W; Zheng X; Inuzuka H; Wang B; Zhang J; Zhang L; Yuan M; Novak J; Cheng JQ; Toker A; Signoretti S; Zhang Q; Asara JM; Kaelin WG; Wei W
Science; 2016 Aug; 353(6302):929-32. PubMed ID: 27563096
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia and the Tumor Microenvironment.
Li Y; Zhao L; Li XF
Technol Cancer Res Treat; 2021; 20():15330338211036304. PubMed ID: 34350796
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.
Haase VH
Exp Cell Res; 2017 Jul; 356(2):160-165. PubMed ID: 28483447
[TBL] [Abstract][Full Text] [Related]
9. Genetic Knockdown and Pharmacologic Inhibition of Hypoxia-Inducible Factor (HIF) Hydroxylases.
Pickel C; Taylor CT; Scholz CC
Methods Mol Biol; 2018; 1742():1-14. PubMed ID: 29330785
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Inducible Factor α and Hif-prolyl Hydroxylase Characterization and Gene Expression in Short-Time Air-Exposed Mytilus galloprovincialis.
Giannetto A; Maisano M; Cappello T; Oliva S; Parrino V; Natalotto A; De Marco G; Barberi C; Romeo O; Mauceri A; Fasulo S
Mar Biotechnol (NY); 2015 Dec; 17(6):768-81. PubMed ID: 26277612
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
Hao X; Ren Y; Feng M; Wang Q; Wang Y
Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
Koivunen P; Kietzmann T
Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue-based research.
Macklin PS; Yamamoto A; Browning L; Hofer M; Adam J; Pugh CW
J Pathol; 2020 Apr; 250(5):593-611. PubMed ID: 32086807
[TBL] [Abstract][Full Text] [Related]
15. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors.
Dalgard CL; Lu H; Mohyeldin A; Verma A
Biochem J; 2004 Jun; 380(Pt 2):419-24. PubMed ID: 14984367
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression.
Stockmann C; Fandrey J
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):968-79. PubMed ID: 17002676
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2018; 1072():171-175. PubMed ID: 30178341
[TBL] [Abstract][Full Text] [Related]
18. Loss of the HIF pathway in a widely distributed intertidal crustacean, the copepod
Graham AM; Barreto FS
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12913-12918. PubMed ID: 31182611
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
Rabinowitz MH
J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
[TBL] [Abstract][Full Text] [Related]
20. Effects of hypoxia and HIFs on cancer metabolism.
Mucaj V; Shay JE; Simon MC
Int J Hematol; 2012 May; 95(5):464-70. PubMed ID: 22539362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
